PMID- 24452843 OWN - NLM STAT- MEDLINE DCOM- 20150128 LR - 20211021 IS - 1432-1173 (Electronic) IS - 0017-8470 (Linking) VI - 65 IP - 6 DP - 2014 Jun TI - [Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine]. PG - 548-52 LID - 10.1007/s00105-013-2747-2 [doi] AB - A woman developed subacute cutaneous lupus erythematosus (SCLE) in 1995 and 2013, each time 6 weeks after initiation of terbinafine therapy. Within the heterogeneous group of drug-induced SCLE terbinafine is considered the most common cause. The clinical, histopathological and laboratory findings of idiopathic and drug-induced SCLE are largely identical. The pathogenesis of drug-induced SCLE is not known. Cytotoxic and immunological mechanisms are considered likely. The treatment of drug-induced SCLE is discontinuation of the suspected drug. In addition, corticosteroids are recommended alone or in combination with chloroquine or hydroxychloroquine. FAU - Wagner, G AU - Wagner G AD - Klinik fur Dermatologie, Allergologie und Phlebologie, Klinikum Bremerhaven Reinkenheide, Postbrookstr. 103, 27574, Bremerhaven, Deutschland, gunnar.wagner@klinikum-bremerhaven.de. FAU - Sachse, M M AU - Sachse MM LA - ger PT - Case Reports PT - Journal Article TT - Arzneimittelinduzierter subakuter kutaner Lupus erythematodes : Wiederholtes Auftreten nach Einnahme von Terbinafin. PL - Germany TA - Hautarzt JT - Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete JID - 0372755 RN - 0 (Antifungal Agents) RN - 0 (Naphthalenes) RN - G7RIW8S0XP (Terbinafine) SB - IM MH - Adult MH - Antifungal Agents/adverse effects MH - Female MH - Humans MH - Lupus Erythematosus, Cutaneous/*chemically induced/*diagnosis/prevention & control MH - Naphthalenes/*adverse effects MH - Recurrence MH - Terbinafine MH - Treatment Outcome EDAT- 2014/01/24 06:00 MHDA- 2015/01/30 06:00 CRDT- 2014/01/24 06:00 PHST- 2014/01/24 06:00 [entrez] PHST- 2014/01/24 06:00 [pubmed] PHST- 2015/01/30 06:00 [medline] AID - 10.1007/s00105-013-2747-2 [doi] PST - ppublish SO - Hautarzt. 2014 Jun;65(6):548-52. doi: 10.1007/s00105-013-2747-2.